Senior Physician
Department of Bone Marrow Transplantation
And Cancer Immunotherapy
Hebrew University Hospital
Ein-Karem, Jerusalem
Tel office: (972-2) 677 8354
mobile: (972-50) 7874 663
Fax: (972-2) 642 2731
E-mail: gashka@hadassah.org.il
Personal Details
Date of birth: May 15th, 1952
Place of birth: Odessa, USSR (Ukraine)
Citizenships: Israeli, Russian
Alyiah: November 1999
Hospital positions
Senior staff member in Bone Marrow Transplantation and Cancer Immunotherapy Department, Hadassah-Hebrew University Medical Center, Jerusalem
Academic position
Associated Professor of Medicine, Hadassah-Hebrew University, Jerusalem, Israel
External Position
Scientific Consultant of Clinical Immunology Dept, Research Institute of Pediatric Hematology, Professor of Pediatrics, Moscow
Languages:
Russian (native), English, Italian, Ukrainian
Education, Professional and Academic Degrees
1969-1973: High Medical School (Basics, Clinics-1), Donetsk (Ukraine)
1973-1975:Pirogov High Medical School (Clinics-2), Odessa (Ukraine)
June, 1975: Medical Doctor Degree (Diploma cum laude); Odessa Pirogov's High Medical School
1975-1976: training internship in medicine, State University, Hospital No 3 (Odessa), National Scientific, Center of Cardiology (Moscow). Certificate in General Medicine
1976-1978: Resident in Pediatrics (ordinatura), Institute of Pediatrics, Academy of Medical Sciences of the USSR, Moscow. Certificate in Pediatrics
1978-1980: Fellowship in Pediatric Allergy/Clinical Immunology (aspirantura, advisor: Prof. T.S.Sokolova), Institute of Pediatrics, Academy of Medical Sciences of the USSR, Moscow
November, 1981: Candidate of Medical Sciences (Ph.D.) Degree
May, 1988: Doctor of Medical Sciences (D.Sci.) Degree.
1992-1993: training in neonatology and pediatric allergy, Instituto Materno Infantile of Palermo University (Italy)/ Advisor: Prof. Giuffre’
1995: Observer in Children’s Hospital and Center for Blood Research, Harvard Medical School (USA). Advisor: Prof. F.Rosen (1 month)
1997: Training in pediatric immunology/bone marrow transplantation unit in Spedali Civili University of Brescia (Italy). Advisor: Prof. L. Notarangelo (4 months)
1998: Certificate of Specialist in Pediatrics (renewed according to new government regulations)
1998: Superior category qualification in pediatrics (certificate)
2000: Certificate of Specialist in Allergy and Clinical Immunology (certified according to a new governmental rules)
2000: Observer in pediatrics, in Hadassah University Hospital, Jerusalem – advisor: Prof. Yatziv (Israel), (6 months)
2000: Israeli Certificate of Specialist in Pediatrics
2005:2000: Observer in allergy/clinical immunology, in Hadassah University Hospital, Jerusalem – advisor: Prof. Naparstek (Israel), (6 months)
2006: Israeli Certificate of Specialist in Clinical Immunology and Allergology
Military Service
1999: Discharged from the Army of the Russian Federation in the rank of Captain, Medical Reserves of the Navy
Appointments In Academic And Research Institutions
1980-1988: Physician and junior investigator, Institute of Pediatrics,Academy of Medical Sciences of the USSR, Moscow.
1988-1990: Senior physician and senior investigator (ibidem)
1990 – 1993: Physician-consultant in allergy/immunology and infection diseases and leading investigator (ibidem)
1993-2003: Head, Dept. of Clinical Immunology, Research Institute of Pediatric Hematology, Moscow
1998-1999:Head, Dept. of Clinical Immunology, Institute of Pediatrics of Russian Academy of Medical Science, Moscow
From 1995: Professor of Pediatrics, Russian State Medical University, Moscow
2004 till present: Scientific Consultant of Dept. Clinical Immunology, Research Institute of Pediatric Hematology, Moscow
2000 till present: Senior staff member, Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah University Hospital, Jerusalem, Israel
2007 till present: Clinical Associate Professor, Hebrew University, Jerusalem, Israel
Other Activities
1986 to 1992: Scientific editor of "Meditzina" publishing house
1987-1989: Member and supervisor of Russian pediatrician teams, working in bad epidemiological regions of Middle Asia Republics (Uzbekistan, Tajikistan)
1988-1990: Expert of the Independent Interdisciplinary Committee in Chernobyl area and Semipalatinsk Nuclear firing ground
1992-1993: Invited researcher of Instituto Materno Infantile of Palermo University and Hospital “Buccheri La Ferla" for the common research in pediatric allergy (Italy).
1994 to 1996: President of "Pediatric Allergy/Immunology Foundation"
1994 till present: Member and vice-president (1995 to 2000) of specialized council D.084.64.01 for doctoral thesis defense.
1996: Visiting researcher, INSERM U430 – Prof. M. Kazatchkine (Paris, France), (2 months)
1997 till present: Member of editorial board of journal "Allergologia" (St Petersburg) (in Russian)
1998 to 1999: Member of editorial board of the Official Russian Pediatric Society Journal "Detsky Doctor" ("Pediatrician") (in Russian)
1998 till present: Free-lance editor of Clinical Immunology heading in "Hematologia i transfusiologia" journal (in Russian).
2002 till present: Member of editorial board of “Pediatric Hematology/Immunology and Oncology” journal (in Russian)
From 2003: Reviewer of "Clinical and Experimental Immunology" (Blackwell Publishing) an official journal of the British Society for Immunology
From 2004: Member of International Scientific Board in Oncology of Istituto Dermopatico dell’Immacolata – IRCCS, Rome, Italy
From 2006: Reviewer of “British Journal of Haematology”
From 2006: Reviewer of “Bone Marrow Transplantation”
From 2007: Reviewer of “Supportive Care in Cancer”
Academic Experience
1982-1986: Invited lecturer in National Post-Graduated Medical Center, Dept of Infection Diseases
1989: Seminar in Clinical Immunology Division, Department of Pediatrics, Johns Hopkins University, School of Medicine, Baltimore (USA)
1991-1992: Supervisor and lecturer of Post-Graduated Pulmonology School of Institute of Pediatrics RAMSc.
1993: Visiting professor, University of Catanzaro (Italy)
1995: Invited professor of Clinical Immunology, Lomonosov Moscow State University
1995: Visiting professor, High Medical School, University of Messina (Italy)
2000: Russian State Diploma of Full Professor in Pediatrics
1995 to 2002: Full Professor of Pediatrics, Russian State Medical University, Moscow
2007 till present: Clinical Associate Professor, Hebrew University, Jerusalem, Israel
Participation in Organizing Committees of Some National or International Congresses (selected)
2002 Aug. 15-17: Chairman, International Symposium on Primary Immunodeficiency Disease (Debrecen, Hungary)
2001 Nov. 5-8: Chairman, IX Meeting of the European Society for Immunodeficiency (Geneva, Switzerland)
1999 Sept. 21-24: President of the 2nd Russian Meeting in Pediatric Hematology, Immunology and Oncology under patronage of ESPHI - European Society for Pediatric Hematology and Immunology (St Petersburg)
1999 Sept. 20-21: Lung diseases in Childhood: Diagnostics, Treatment, Prophylactics (National, Moscow)
1999 April 19-23: Annual National Congress "Human and Medicine" (Moscow, a member of scientific committee)
1999 Sept. 6-10: A second congress of Russian Society of Immunology (Sochi, a member of scientific committee)
1998: Annual National Congress "Human and Medicine" (Moscow, a member of scientific committee, head of the jury of competition in Immunology)
1997: Annual National Congress "Human and Medicine" (Moscow, a member of scientific committee)
1994: International Meeting " Pediatric allergy and clinical immunology" (President, Moscow)
Memberships
1. WHO Scientific Committee for Primary Immunodeficiency Disorders (since1994)
2. British Society for Immunology (since 1997)
3. Russian Pediatric Society (member of the Council in 1994-1996)
4. European Society for Immunodeficiency (ESID) (since 1992)
5. International Union of Immunology Societies (IUIS) (member of Scientific Committee till 2003)
6. Russian Association of Allergy and Clinical Immunology (since 1998)
7. Russian Society for Immunology (since 1999)
8. European Society of Pediatric Allergy and Clinical Immunology (ESPACI) (1990-1995)
9. Israeli Medical Association (from 2000)
Grants (The Last Ten Years)
1993-1995: Mutation analysis and molecular diagnostics of primary immunodeficiency disorders with focus on btk-gene, principal investigator, grant RosNeft, Russia (USD 20,000/20,000 per year).
1995-1997: Inflammatory mechanisms in bronchial asthma, airways hyper-reactivity and anti-inflammatory treatment approaches, principal investigator, supported by Research Institute for Pediatric Hematology, Moscow (app. equal to USD 7,000/7,000 per year).
1997: Self-reactive antibody repertoire in different primary defects of antibody production, investigator, INSERM U430 in collaboration with Pasteur Institute, Paris, France and Research Institute for Pediatric Hematology, Moscow, Russia; EC/PECO grant (FF 75,000/75,000).
1997: NBS1 gene 657del5 mutations origin and effects of homo- and heterozygosity for telomere length and cell growth potential, human immune,: Self-reactive antibody repertoire in different primary defects of antibody production (extension of study from 1997), investigator, INSERM U430 and hematopoietic systems and cancer predisposition, principal investigator, supported by grant of the A-T Medical Research Foundation, Los Angeles, USA (USD 3,000/3,000); part of this work was performed in collaboration with Molecular Genetics Program, Virginia Mason Research Center, Seattle, Department of Immunology, University if Washington School of Medicine supported by the National Cancer Institute grant CA57569, and Center for Blood Research, Boston, supported by NIH grant CA54326 and CA79658 (budgets unknown).
1998INSERM U429, Paris, France in collaboration with Research Institute for Pediatric Hematology, Moscow, Russia; EC/PECO grant (FF 75,000/75,000)
1998-1999: Library of Clinical Immunology Department support, Jeffrey Modell Foundation, New York, USA (USD 4,000/4,000 per year).
1999: Evaluation of effectiveness of IVIG treatment for primary immunodefficiencies and autoimmune disorders, personal grant, USD 3,000/3,000. Biotest grant.
1999-2002: Place and mechanisms of apoptosis in maintenance of immune homeostasis in human, principal investigator, Research Institute for Pediatric Hematology, Moscow, Russia; grant 99-04-48868 of Russian Foundation for Basic Researches for 1999-2002 (app. equal to USD 10,000/10,000 per year).
2004-2005: Development of a new method for rapid assessment of lymphocyte activation based on time domain dielectric spectroscopy. Principal investigator. With the Department of Applied Physics. Grant of Israel Cancer Association; NIS 20,000/45,000.
2005-2006: Development of a new method for rapid assessment of lymphocyte activation based on time domain dielectric spectroscopy. Principal investigator. With the Department of Applied Physics. Grant of Yeshaya Horowitz Association; USD 20,000/45,000
2009-2010: Nanophotonic-microfluidic plaform for single cells handling and Evaluation With the Department of Applied Physics. Principal investigator.Ministry of Science and Technology, USD 100,000
Teaching And Research In Hebrew University
Courses (in HU): from 2000, annual courses in (i) hematology, (ii) oncology and bone marrow transplantation, (iii) introduction to medicine (physical examination) and from 2002 (iv) lab hematology in School of Medicine, Hebrew University, Jerusalem
Run Laboratory In Hadassah-Hebrew University
3 PhD, 1 MD, 1 BA (Gregory Elkin, Olga Gurevich, Tanya Prigozhina, Clo Barkatz, Lyudmila Rheingold)
Current External Scientific Activity
Scientific Consultant of Dept. Clinical Immunology, Research Institute of Pediatric Hematology, Moscow
Honorary Professor of Moscow State Medical University, Moscow, Russia from 2009
Member of Strategy Committee of Practical Research Hagassah Medical Organization, Jerusalem, Israel from 2009.
Postgraduate Students, postdoctorals and fellows
The following have been graduated or continue their investigation under my direct supervision in pediatrics (specialization code 14.00.09), hematology and transfusiology (14.00.29), allergy and immunology (14.00.36), applied physics (HUJI):
14 PhD students and 2 postdoctoral investigators
Multicenter/International And Ongoing Clinical Trials (Selected)
1993: A multicenter study of Salmeterol effectivenes and safety in young asthmatic children. SLMP02 (Centro Ricerche GLAXO) 1993 (investigator – in Italy)
1998: A double-blind evaluation of safety and tolerability of a new HFA-propelled salbutamol metered-dose inhaler with a conventional CFC- propelled salbutamol metered in children with asthma. Protocol number: IX-105-105. Norton Healthcare LTD (principal investigator).
1998-1999: A multicenter, randomized, Double-blind, Parallel Group Clinical Trial to compare the efficacy and safety of fluticasone propionate (FP) 200 µg/day with fluticasone propionate 400 µg/day administered for 16 weeks via a multidose powder device (Diskus) to pediatric patients with asthma. Protocol code FAS30006. GlaxoWellcome. December 1998 – February 1999 (principal investigator).
1999-2001: A 6-month comparison of the safety and efficacy profiles of Oxis® (formoterol) Turbuhaler® as needed and Bricanyl® (terbutaline) Turbuhaler ® as needed in children with asthma on anti-inflammatory treatment. Study code SD-037-0695. Phase of development: III a. Study design: Parallel group, double-blind, reference controlled, randomized. AstraZeneca (principal investigator)
2000 till present: Ongoing Phase II/III multi-center open label randomized clinical trial evaluating ABX-CBL when compared to clinical trial evaluating ABX-CBL when compared to ATGAM ® as second line therapy in patients with steroid resistant acute graft versus host disease (Abgenix USA).
2001 till present: Treatment of gastro-intestinal graft versus host disease with budesonide in patients following peripheral blood stem cell transplantation.
2001 till present: Creation of bone marrow microinviroment for treatment of myelodisplastic syndromes in conjunction with autologous and allogeneic stem cell transplantation.
2004 till present: GvHD prophylaxis with ATG-Fresenius S in allogeneic Stem Cell Transplantation from matched unrelated donors:
A randomized phase III multicenter trial comparing a standard GvHD prophylaxis with cyclosporine A and methotrexate with additional pretransplant ATG-FRESENIOUS S.
2004 till present: Phase III trial of a nonmyeloablative preparative regimen with fludarabine and busulfan with or without anti-lymphocyte antibodies (CAMPATH-1H or ATG) for patients with acute myelogenous leukemia or myelodysplastic syndrome undergoing allogeneic Stem Cell Transplantation from an HLA compatible donor.
2005: A prospective randomized, controlled pilot study in order to evaluate the place of Thymoglobuline in non-myeloablative allogeneic hematopoietic Stem Cell Transplantation (NST).
2006: Assesment of Efficacy of Pain Control with the use of Virtual Reality Immersion Method in Post-BMT Patients. (Clinical Trial) Principal Investigator. With Department of Anesthesiology and Sonarion-Hadassah Academic VR Center; Preparatory stages.
List of Publications
Theses
1. Resnick IB. [Prostaglandins in pediatric asthma.] Candidate of Sciences (PhD) Dissertation. Moscow 1981: 215 pp. Manuscript in Russian. Resulted to 17 publications: 6 original articles (Original articles:3,5-7,10,11), one review article (Reviews:77), 2 proceedings (Proceedings: 2,4), 7 abstracts (Abstracts: 1-6,9) and published in Moscow as Essentials (Original articles: 4).
2. Resnick IB. [Mechanisms of pediatric asthma development and its therapy.] Doctor of Sciences (DSci) Dissertation. Moscow 1988: 310 pp. Manuscript in Russian. Resulted in 28 publications: 9 original articles (Original articles: 8,9,12-14,16-19), 2 review articles (Reviews: 80,81), 4 proceedings (Proceedings: 3,5-7), 12 abstracts (Abstracts: 7,8,10-19) and published in Moscow as Essentials (see Original articles: 15).
Books and Manuals
3. Balabolkin II, Zgukovski AM, Resnick IB.(1986) Clinical presentation, diagnostics and treatment of hay fever. Manual. Moscow [in Russian].
4. I.Resnick, O.Danhaive V.Rosella U.Dimita. L'asma in pediatria. Manuale teorico prattico [Pediatric asthma: Theory and practice. Manual]. Plada S.p.A.,Milano, 1994. [in Italian].
5. Bronchial asthma in children: A treatment strategy and prophylaxis – Consensus group final document / Ed. – Prof. A.G. Chuchalin. Moscow, 1997 [in Russian].
6. Kondurina E, Gavalov SM, Resnick IB. [Evaluation of pediatric asthma prevalence using ISAAC program.] A method description (Russian version). Moscow, 1998 [in Russian].
7. Resnick I.B., Kondratenko I.V., Sidorenko I.V. Primary Immunodeficiencies. Manual for physicians. Ministry of Health, Moscow – 2002 [in Russian].
8. Sidorenko IV, Leshkevich IA, Kondratenko IV, Gomes LA, Resnick IB. Diagnostics and treatment of primary immunodeficiency". Manual. Moscow Government publication, Moscow, 2000
Books Edited
9. Rosen F.S., R.J.P. Wedgwood, M.Eibl, A.Fischer, F.Aiuti, L.Notarangelo, T.Kishimoto, I.B.Reznick, L.Hammarstrom, R.Seger, H.Chapel, R.A. Thompson, M.D.Cooper, R.S.Geha, R.A.Good, T.A. Waldmann. Primary Immunodeficiency Diseases. Pediatric asthma (With editor comments and appendix) / Ed. – IB Resnick, Altus-Moscow, 1996 [in Russian, translated from English]
Chapters In Collections
10. Torubarova NA, Kosel IV, Savinskij AK, Reznik IB (1977). [Use of some para-clinical parameters in as predictors of aplastic anemia outcome in children.] In: Theory and practice in medicine/ Ed. – Prof. M. Studenikin. Book 2: pediatrics and pediatric surgery. Moscow: p. 201-204 [in Russian].
11. Resnick I.B. (1986) Metabolic and cellular basis of the allergic reactions development. Chapter 4. In: Allergic diseases in childhood / MY Studenikin and TS Sokolova eds.- Moscow, Meditzina [in Russian].
12. Resnick IB. [Mechanisms of pediatric asthma development and its therapy.] In: Soviet Pediatrics (book 4)/ Prof. MY Studenikin – editor. Moscow, 1986: 187-201 [in Russian].
13. I.Resnick (1995). Primary immunodeficiencies as a tool for analysis of human immune system. In: Ilya Mechnikov – a great son of Ukraine and humanity. Odessa 1995 p. 37-41 [Invited lecture] [in Russian].
14. I.Reznick, J.Kulak, A.J.Usacheva, I.Konakova, L.G.Dubovik, G.I.Kovalev (1997). Using of Tayled in the treatment of pediatric asthma. In: “National Program for Pediatric Asthma” Moscow: p 52-60 [in Russian].
15. I.Resnick (1997) Characteristics of inflammation in pediatric asthma. - Child: Health Plan' 97. International Meeting; Ancona (Italy) 1997: 153-158. [Invited main lecture]
16. Resnick IB (1999). [Primary immunodeficiencies: lecture.] Selected topics in Therapeutic Medicine/ Ed. – Prof. A. Chuhalin, Moscow: 82-88. [Invited lecture] [in Russian]
17. IB Resnick, I.Kondratenko, I.Molotkovskaya, E.Konopleva, Y.Reznicov, L.Baydun, V.Poverenny, F.Rieux-Laucat, F. Le Deist (2000). Autoimmune Lymphoproliferative Syndrome (ALPS) in Children. IX Meeting of the European Society for Immunodeficiencies. /Prof. A.Etzioni - ed. Monduzzi Editore S.p.A.: p.197-205 [Invited lecture].
18. Paschenko OE, Kouznetsova MA, Yurasova AS, Sidorenko IV, Pachanov ED, Bologov AA, Prodeus AP, Resnick IB, Kondratenko IV (2002). Spectrum of infections in the primary immunodeficiencies. In textbook: Clinical immunology and allergy / Ed. – Prof. AV Karaulov, Moscow. Vol.3. p. 80-96 [in Russian].
19. Slavin S, Aker M, Shapira MY, Resnick I, Bitan M, Or R (2003). Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders. Chapter in Clin Transpl / . Eds: J. Michael Cecka & P. Terasaki (UCLA); p. 275-82.
Original Articles
PI-principal investigator, C-co-investigator, S-student, T-technician, in bold – attached papers which represent my research interests.
20. Torubarova NA PI, Kosel IV C, Savinskij AK PI, Reznik IB C (1980) [Prognostic factors of juvenile aplastic anemia]. Problemy Gematologii i Transfusiologii; vol. 25 (26): 18-21*.
21. Reznik IB PI (1980). [Prostaglandins in bronchial asthma in children]. Pediatriia. Jul;(7):35-8 [Article in Russian]. (5;5)
22. Torubarova NA PI, Kosel IV C, Savinskij AK PI, Cistopolskij AS C, Jesimova SS S, Reznik IB C, Zarov VN C, Aldarov AT C (1981). Retrospektive Analyse yon 61 Fallen erworbener hypoplastischer Anamie bei Kindern.Prognose bes timmende Faktoren [Retrospective analysis of 61 cases of acquired juvenile hypoplastic anemia. Factors determining the prognosis]. -Folia Haematol Int Mag Klin Morphol Blutforsch. Bd.108(6): 778-85 [Article in German].
23. Resnick IBPI (1981). Prostaglandins in pediatric asthma. Essentials of Candidate of Sciences (PhD) thesis, Moscow: 16 pp. *
24. Resnick IB PI, Sokolova TS C, Markov CM C (1981). [Influence of asthma treatment with aminophyllin on plasma prostaglandin levels.] Voprosy okhrany materinstva i detstva. (Russian, English abstract); vol. 26; 5: 37-41*
25. Sokolova TS PI, Iurkov IuA PI, Bakanov MI C, Reznik IB C, Zakhidov IuV C (1983). [Mediator disorders in atopic bronchial asthma in children, and problems of therapy.] Pediatriia Mar;(3):11-3 [Article in Russian]
26. Reznik IB C, Dombrovskaia IA C, Drozdov NP C, Markov KM C (1983). [Prostaglandin content of the venous blood of healthy children]*.Pediatriia. May;(5):14-5 [Article in Russian]. (1;1)
27. Yurkov YA C, Sokolova TS C, Bakanov MI C, Resnick IB PI (1983). Cyclase system and prostaglandins in pediatric asthma. Voprosy okhrany materinstva i detstva. [Article in Russian, English abstract]; vol 28; 3: 16-20. *
28. Resnick IB PI, Bespalko NN C (1983). Some allergic reaction mediators in serum of children with asthma.. Voprosy okhrany materinstva i detstva.; vol 28; 3: 14-16 * [Article in Russian, English abstract]
29. Sokolova TS C, Reznik IB PI, Markov CM C (1984). - Papel de las prostaglandinas en la patogenia del asma bronqual en ninis y posibilidades en el tratamiento terapeutico [Role of prostaglandins in the pathogenesis of bronchial asthma in children and possibilities in therapeutic treatment] - Allergologia et immunopathologia (Madr). Jul-Aug;12(4):267-73. [Article in Spanish].
30. Reznik IB PI, Yurkov IA C, Bakanov MI C, Bespal'ko NN C (1985). [Mechanism of action of euphylline in atopic bronchial asthma in children]. Pediatriia. Aug;(8):22-4. [Russian].
31. Sokolova TS PI, Mikhailova ZM C, Resnick IB PI (1986) [Clinical and immune characteristics of pollinosis.] Voprosy okhrany materinstva i detstva. [Russian, English abstract]; vol 31; 3: 24-28. *
32. Resnick IB PI, Torubarova NA C, Alymkulova ED S (1988). [PBMC characteristics in childhood asthma (analysis with mAbs).] Voprosy okhrany materinstva i detstva. (Russian, English abstract); vol 33; 8: 38-42 *
33. Resnick IB PI, Popov KM C, Eshba IR C, Severin SE PI (1988). System of cyclic AMP regulation in pediatric asthma. Pediatria (manuscript deposed in SURI of Medical Information, Ministry of Health of USSR; N1546488 – Moscow): 12 pp. Abstract published in Medical Abstracts Journal – V. Pediatrics [in Russian], 9, N2076*
34. Resnick IBPI (1988). Mechanisms of pediatric asthma development and its therapy. Essentials of Doctor of Sciences thesis, Moscow: 43 pp. *
35. Balabolkin II PI, Reviakina VA C, Resnick IB C (1988) [Second messenger system and membrane lipids metabolism in pediatric atopic disease.] Manuscript, 33 p. SUSTI center, N02870017542. *
36. Balabolkin II PI, Reviakina VA C, Resnick IB PI (1988) [Interaction of some immune and mediator systems in allergic diseases in childhood; approaches to the treatment.] Manuscript, 15 p. SUSTI center, N02840042291. *
37. Resnick IB PI, Jazdovski VV PI, Bachurin, PS C (1988). [HLA and predisposition to polyvalent sensitization in atopy in childhood.] Pediatria, N2: 17-19. *
38. Reznik IB PI, Voronov V C, Ivanov VG C, Turina IE C, Karaulov AV C (1989). [The diagnostic value of determining total IgE in atopy in children]. Lab Delo;(3):20-4 [in Russian].
39. P. Macchi PI, A. Villa PI, Strina D C, Sacco MG C, Morali F C, Brugnoni D C, Giliani S C, Mantuano E C, Fasth A C, Andersson B C, Zegers BJM, Cavagni G, I.Resnick C, Levy JC, Zan-Bar IC, Porat YC, Airo PC, Plebani AC, Vezzoni PC, Notarangelo LPI. (1995). Characterization of Nine Novel Mutations in the CD40 Ligand Gene in Patients with X-linked Hyper IgM Syndrome of Various Ancestry. American Journal of Human Genetics, 56(4):898-906 (11.602;9/120;30;30)
40. L.Notarangelo PI, M.Peitsch C, D.Brugnoni C, T.G.Abrahamsen C, K.Aittomaki C, P.Bordigoni C, M.Clemanti C, A.Etzioni C, A.Fasth C, L.Gomez C, A.Jones C, J.Levi C, N.Matamoros C, V.Monafo C, I.Resnick C, O.Sanal C, P.A.Tovo C, B.M.J.Zegers C, A.Villa PI (1996). CD4OLbase: a database of CD4OL gene mutations causing X-linked hyper -lgM syndrome. Immunology Today/Trends in Immunology, 17 (11): 511-6 (18.153;4/114;62;60)
41. M.Vihinen PI, Rik A. Brooimans C, Sau-Ping Kwan C, Heikki Lehväslaiho C, Gary W. Litman C, Hans D. Ochs C, Igor Resnick C, Jerrold H. Schwaber C, Igor Vorechovsky C and C. I. Edvard Smith PI (1996). BTKbase: XLA-mutation registry.- Immunology Today/Trends in Immunology, 17 (11): 502-506 (18.153;4/114;36;35)
42. I.B.ResnickPI, G.I.KovalevC, E.D.PashanovC, I.KondratenkoC (1996) Leukocyte adhesion deficiency: a rare form of primary immunodeficiency. Pediatria 5: 26-31[in Russian].
43. Levy J PI, Espanol-Boren T C, Thomas C C, Fischer A C, Tovo P C, Bordigoni P C, Resnick I C, Fasth A C, Baer M C, Gomez L C, Sanders EA C, Tabone MD C, Plantaz D C, Etzioni A C, Monafo V C, Abinun M C, Hammarstrom L C, Abrabamsen T C, Jones A C, Finn A C, Klemola T C, DeVries E C, Sanal O C, Peitsch MC C, Notarangelo LD PI (1997). Clinical spectrum of X-linked hyper-IgM syndrome.- J Pediatr, Jul 131:1 Pt 1 47-54 (2.913;5/68;143;142)
44. I.Resnick PI, J.Kulak C, A.Usacheva C, A.Scherbina C (1997). Characteristics of airways inflammation in paediatric asthma. Pediatria [in Russian], N2: 9-14 (1;1)*
45. E.Pashanov C, A.Fischer C, I.Resnick C, E. Haddad C, J-L.Casanova PI (1997). B-cell lymphoproliferative syndrome remission after a second BMT achived with mAbs to IL-6. Pediatria, N4: 127-129*
46. I.Kondratenko C, A.Bologov C, A.Y.Usacheva C, I.Resnick PI (1997). Common variable immune deficiency: clinical presentation with development of aplastic anemia. Pediatria, N4: 45-49*
47. Resnick IB PI, G.Kovalev C, I.Kondratenko C, A.Bologov C, F.LeDeist C, A.Fischer PI (1997). Autoimmune lymphoproliferative syndrome: a novel type of primary immunodeficiency. Pediatria, N4: 42-44 *
48. Resnick I. B. PI, Kondratenko I. V. C, Ataeva D. M. C, Kuleshov N. P. C, Maschan A. A. C, Lucia D. Notarangelo C, Luigi D. Notarangelo C (1998). Primary immunodeficiency with microcephalia: clinical presentation, immunological and hematological disorders in various syndromes. Hematologia – Transfusiologia, vol.43, 2: 28-33. (1;0) *
49. Konopleva E. A. S, Kondratenko I. V. C, Molotkovskaya I. M. C, Sapozhnikov A. M. C, Zelenova N. A. C, Baidun L. V. C, Reznikov Yu. P. C, Bologov A. A. C, Kovalev G. I. C, Reznik I. B. PI (1998). Clinical and immunological characteristics of patients with autoimmune lymphoproliferative syndrome. Hematologia–Transfusiologia, vol.43, 5: 32-36*
50. I.Resnick PI, L.Notarangelo PI, A.Villa PI, S.Giliani C, I.Kondratenko C, G.I.Kovalev C, T.Arefjeva C, L.Gomes C, A.Bologov C, Y.Reznikov C (1998). Genetic and immunological characteristics of X-linked hyper-IgM syndrome: a description of four unrelated cases. Immunologia; N2:22-24 *
51. I.Resnick PI, S.Tverskaja C, V.Bobrynina C, I.Kondratenko C, G.Kovalev C, A.Bologov C, O.Evgrafov C (1998). Molecular genetic analysis of patients with X-linked agammaglobulinemia (BTK gene analysis). Immunologia; N2:18-22 *
52. I.V.Konakova S, J.Kulak C, L.G.Dubovic C, D.S.Matcharadze C, I.B.Resnick PI(1998). Zafirlukast (accolate) in the treatment of moderate to severe pediatric asthma. Allergologia, №4: 4-7*
53. Kondratenko IV C, Bologov A. A. C, Gomes L. A. C, Reznik I. B. PI (1998). X-linked lymphoproliferative syndrome: clinical variants. Hematologia –Transfusiologia; vol. 43, 4: 39-42 *
54. Reznik I. B. PI, Kondratenko I. V. C, Kovalev G. I. C, Bologov A. A. C, Gomes L. A. C, Vasserman N. N. C, Tverskaya S. M. C, Evgrafov O. V. C (1998). Two novel mutations in X-linked agammaglobulinemia (Bruton’s disease). Hematologia –Transfusiologia; vol. 43, 6:34-37 *
55. Vihinen M PI, Kwan SP C, Lester T C, Ochs HD C, Resnick I C, Valiaho J C, Conley ME C, Smith CI C (1999). Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia. -Hum Mutat;13(4):280-5 (6.328;14/120;46;46)
56. S.Lacroix-Desmazes C, I.Resnick PI, L.Mouthon S, H.Ochs C, A.Fischer C, T.Espanol C, J.Levi C, M.Eibl C, L.Notarangelo C, S.V.Kavery C, M.D.Kazatchkine PI (1999). Defective self-reactive antibody repertoire in patients with the hyper-IgM syndrome. -J Immunology; 162: 5601-5608 (6.702;11/114;13;13)
57. M.Kouznetsova C, I.Kondratenko C, H.Ochs C, A.Fischer C, T.Espanol C, J.Levi C, M.Eibl C, L.Notarangelo C, I.Resnick PI(1999). [Agammaglobulinemia with elevated IgM: clinical and immunological presentations and treatment principles.] Hematologia –Transfusiologia; vol. 44, 5: 40-43 *
58. Konakova IV S, Macharadze D C, Resnick IB PI(1999). [Montelukast in treatment of pediatric exercise-induced asthma.] Pediatriia, №2, 45-49. [Russian] *
59. Scherbina A. Yu. C, Bretcher A. C, Rosen F. S. C, Rumyantsev A. G. C, Remold-O’Donnell E PI, Reznik I. B C. (1999). Low concentration of moezin, a cytoskeletal protein, in platelets of patients with Wiskott-Aldrich syndrome. Hematologia – Transfusiologia, vol.44, 4: 17-21 *
60. Kuznetsova M. A.C, Kondratenko I. V. C, Reznik I. B. PI (1999) Agammaglobulinemia with elevated level of IgM: diagnostic criteria, clinical and immunological characteristics, approaches to therapy. Hematologia – Transfusiologia, vol.44,6: 47-47 *
61. Reznik I. B.PI, Togoev O. OC., Kondratenko I. V.C, Evgrafov O. IC., Conkennon PC. (1999). Molecular and immune defects in chromosome breakage Nijmegen syndrome. Hematologia – Transfusiologia, vol.44,6: 47-47 *
62. Ranganathan V S, Heine WF C, Ciccone DN C, Rudolph KL C, Wu X C, Chang S C, Hai H C, Ahearn IM C, Livingston DM C, Resnick I C, Rosen F PI, Seemanova E C, Jarolim P C, DePinho RA C, Weaver DT PI (2001). Rescue of a telomere length defect of Nijmegen breakage syndrome cells requires NBS and telomerase catalytic subunit. Curr Biol; Jun 26;11(12):962-6 (11.910;7/216;26;26)
63. Usacheva AY C, Najimov VP C, Bologov AA C, Resnick IB PI (2001) Progressive myositis ossificant in children. Pediatriia; N4: 60-66 *
64. E.Konopleva S, J.Kulak C, I.Konakova S, Ju.P.Reznikov C, I. Resnick PI (2001). A place of double-blind placepo controlled food challenge test in diagnostics of food intolerance in children. Paediatrija, N4: 43-7 *
65. Kondratenko IV C, Galkina EV C, Bologov AA C, Pachanov ED C, Resnick IBPI(2001). Wiskott-Aldrich syndrome: clinical presentation and conservative treatment. Pediatriia; N4: 29-35 *
66. Konopleva EA S, Kondratenko IV C, Molotkovskaya IM C, Baidun LV C, Reznikov YP C, Najimov VP C, Bologov AA C, Resnick IB PI(2001). Variants of cellular immune defects in children with autoimmune lymphoproliferative (Canale-Smith) syndrome. Pediatriia; N4: 23-28 *
67. Kondratenko IV PI, Litvina MM C, Resnick IB C, Yarilin AA C(2001). T cell mediated immunity disorders in patients with common variable immune deficiency. Pediatriia; N4: 18-22 *
68. Igor B. Resnick PI, Oleg Togoev C, Irina Kondratenko C, Pachanov ED C, Oleg Evgrafov C, Svetlana Tverskaya C, Natalia Vasserman C, Irena Shagina C(2001). The founder effect in Nijmegen breakage syndrome. Pediatriia; N4: 14-17 *
69. Resnick IB PI, Kouznetsova MA C, Pashanov ED C, Lacroix-Desmazes S C, Stahl D C, Espanol T C, Levy J C, Kaveri SV C, Notarangelo L C, Eibl M C, Fischer A C, Ochs H C, Kazatchkine M. PI(2001). Failure of immune balance and antibodies repertoire formation in genetic and acquired defects of CD40L-CD40 interactions (hyper-IgM syndrome). Pediatriia; N4: 9-13[in Russian] *
70. IB Resnick PI, I Kondratenko C, O Togoev S, N Vasserman S, I Shagina S, O Evgrafov C, S Tverskaya C, KM Cerosaletti S, RA Gatti C, P Concannon C (2002). Nijmegen breakage syndrome: Clinical characteristics and mutation analysis in 8 unrelated Russian families. J Pediatrics; 140:355-61 (2.913;5/68;20;19)
71. Kondratenko IV PI, Sidorenko IV C, Ilyina NI C, Bologov AA C, Latysheva TV C, Prodeus AP C, Scherbina AY C, Paschenko OE S, Yurasova AS S, Konopleva EA C, Usacheva AYC, Kouznetsova MA C, Pachanov ED C, Setdikova N C, Resnick IBPI (2002). Registry of the primary immunodeficiencies. Pediatric Hospital, 2, 8: 18-23. [in Russian]*
72. Yurasova AS S, Kharybina EI C, Kouznetsova MA C, Resnick IB PI, Kondratenko IV C (2002). Anogenital papillomatosis in a patient with ataxia-telangiectasia. J Pediatric Oncology, Hematology and Immunopathology [in Russian]*
73. Kondratenko IV C, Kouznetsova MA C, Togoev OO C, Paschenko OE S, Zgeludkova OG C, Pachanov ED C, Karachunski AI C, Litvinov DV C, Maschan MA C, Baidun LV C, Bologov AA C, Resnick IB PI (2002). Malignancies spectrum in patients with ataxia-telangiectasia. J Pediatric Oncology, Hematology and Immunopathology vol.1 (1): 44-47. [in Russian]*
74. MY Shapira PI, AI Bloom C, R Or C, T Sasson C, I Resnick C, A Nagler C, M Aker C, I Zilberman C, S Slavin C, A Verstandig C (2002). Intra-arterial catheter directed therapy for severe graft vs. host disease (GVHD) Br J Haematology; 119:760-764. (3.267;14/62;2;1)
75. Kondratenko IV C, Resnick IB C. (2002) Primary immunodeficiencies. J Pediatric Oncology, Hematology and Immunopathology vol.1(2): 40-46 [Invited article]. [In Russian] *
76. Elad S C, Or R C, Resnick IB C and Shapira MY PI (2003). Topical tacrolimus – a novel treatment alternative for cutaneous chronic graft versus host disease. Transplant int vol. 16(9):665-70. (1.204;53/141;13/18;4;4)
77. R Or PI, M Shapira C, I Resnick C, A Amar C, A Ackerstein C, S Samuel T, M Aker C, E Naparstec C, A Nagler C, S Slavin PI (2003). Non-myeloablative allogeneic stem call transplantation for the treatment of chronic myeloid leukemia in first chronic phase. Blood, Vol. 101, No. 2, pp. 441-445. (10.120;2/62;34;32)
78. Shapira MY C, Or R C, Resnick IB C, Bitan M C, Ackerstein A C, Samuel S T, Elad S C, Zilberman I C, Miron S C and Slavin S PI (2003) A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant vol 32 (2): 557-561. (2.172;60/120;23/62;55/114;9/18;0)
79. Bitan M C, Resnick I C, Or R C, A Rokach C, U Laxer C, A. Ackerstein C, Slavin S C and Shapira MY C (2003). Rhinolalia as a presenting sign of pneumomediastinum complicating bronchiolitis obliterans. American J Hematology 74(3):182-6 (1.667;32/62;0)
80. Resnick IB PI, Kondratenko I C, Pashanov E C, Maschan AA C, Karachunsky A C, Togoev O S, Timakov A C, Polyakov A C, Tverskaya S C, Evgrafov O C, Roumiantsev AG C (2003). 657del5 mutation in the gene for Nijmegen breakage syndrome (NBS1) in a cohort of Russian children with lymphoid tissue malignancies and controls. Am J Med Genet; 120A (2):174-9. (2.603;54/120;1;1)
81. Shapira MY C, Or R C, Resnick IB C, Bitan M C, Slavin S PI (2003). Quantitative RT-PCR after NST for CML. Blood; 101(12): 5084-5 (10.120;2/62;0)
82. Kondratenko IV C, Yurasova AS S, Tverskaya SM C, Evgrafov OI C, Resnick IB PI (2003). Experience in prenatal diagnostics of primary immunodeficiencies. J Pediatric Oncology, Hematology and Immunopathology. Vol. 2(4); 84-86 [In Russian, English abstract]
83. Barkan D C, Nusair S C, Resnick IB C, Bitan M C, Segel MJ C, Or R C, Ackerstein A C, Samuel S C, Breuer R C and Shapira MY C (2004) Tube thoracostomy during allogeneic stem cell transplantation does not carry an increased risk for infections or bleeding. Clin Transplant vol. 18(1):85-8. (1.582;43/141;12/18;0)
84. Bloom AI PI, Shapira MY PI, Or R C, Sasson T C, Resnick IB C, Zilberman I C, Verstandig A C, Aker M C, Slavin S C, Muszkat M C (2004). Intrahepatic arterial administration of low-dose methotrexate in patients with severe hepatic graft-versus-host disease: an open-label, uncontrolled trial. Clin Ther. Vol. 26(3): 407-14 (2.670;47/185;0)
85. Shapira MY C, Resnick IB C, Bitan M C, Ackerstein A C, Samuel S C, Elad S C, Miron S C, Zilberman I C, Slavin S PI, Or R C (2004). Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients. Bone Marrow Transplant ;34(2):155-9. (2.172;60/120;23/62;55/114;9/18;0)
86. Or R C, Aker M C, Shapira MY C, Resnick I C, Bitan M C, Samuel S C, Slavin S PI. (2004) Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products. Springer Semin Immunopathol. (1-2):133-42.(0.918;94/114;49/64;0)
87. Shapira MY PI, Hirshfeld E C, Weiss L C, Zeira M C, Kasir J C, Or R C, Resnick IB C, Slavin S PI. (2005) Mycophenolate mofetil does not suppress the graft-versus-leukemia effect or the activity of lymphokine-activated killer (LAK) cells in a murine model. Cancer Immunol Immunother. 54(4):383-8 (3.13; 3/120; 29/114).
88. Bitan M PI, Or R C, Shapira MY C, Resnick IB C, Ackerstein A C, Samuel S C, Elad S C, Slavin S PI. (2005) Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent. Haematologica. 90(8):1089-95 (IF 4.192).
89. Shapira M PI, Adler SN C, Jacob H C, Resnick IB C, Slavin S C, Or R C (2005) New insights into the pathophysiology of gastrointestinal graft-versus-host disease using capsule endoscopy. Haematologica. 90(7):1003-4 (IF 4.192).
90. Bitan M PI, Shapira MY C, Resnick IB C, Zilberman I C, Miron S C, Samuel S C, Ackerstein A C, Elad S C, Israel S C, Amar A C, Fibach E C, Or R C, Slavin S C (2005) Successful transplantation of haploidentically mismatched peripheral blood stem cells using CD133(+)-purified stem cells. Exp Hematol 33: 713-8 (IF 4.12)
91. Resnick IB C, Slavin S PI (2005) Lessons from bone marrow transplantation for a victim of radiological accident with an acute radiation syndrome. Br J Radiol. Suppl. 2005; 27:21-5 (1.089;55/83)
92. Blatt A. PI, G. Cotter C, M. Leitman C, R. Krakover C, I.B. Resnick C, S. Samuel C, D. Gozal C, Z. Vered C, S. Slavin C, MY Shapira PI (2005) Intra-Coronary Administration of Autologous Bone Marrow Mononuclear Cells after Induction of Short Ischemia is Safe and May Imporve Hibernation and Ischemia in Patients with Ischemic Cardiomyopathy. American Heart Journal 150(5): 986.e1-986.e7 (IF 3.3).
93. Bitan M PI , Or R C,, Shapira M C, Aker M C, Resnick I C, Elad S C, Slavin S C (2006) Fludarabine-based non-myeloablative conditioning for stem cell transplantation of Fanconi’s anemia patients from fully matched related and unrelated donors. Biology of blood and marrow transplantation Jul;12(7):712-8 12(7):712-8 (IF 2.88).
94. Shapira MY PI, Resnick IB C, Bitan M C, Ackerstein A C, Tsirigotis P C, Gesundheit B C, Zilberman I C, Miron S C, Leubovic A C, Slavin S C and Or R C. (2005) Rapid response to alefacept given to patients with steroid resistant or steroid dependent acute graft versus host disease - a preliminary report Bone Marrow Transplantation 36(12):1097-101(2.554; 3/16; 41/107; 16/59; 39/114; 0).
95. Resnick IB PI, Averbuch D C, Aker M C, Engelhard D C. (2005). Is Pneumocystis carinii pneumonia after stem cell transplantations a contagious disease? Clin Transplant 19(3):427-31 (1.582;60/120;23/62;55/114;9/18)
96. Igor B. Resnick PI, Abdul-Hai Ali C, Michael Y. Shapira C, Menachem Bitan C, E. Hershkovitz C, Israel Matot C, A. Schwartz C, Reuven Or C, Shimon Slavin C, Yoseph Kapelushnik PI (2005) Treatment of X-linked childhood cerebral adrenoleukodystrophy by the use of an allogeneic stem-cell transplantation with reduced intensity conditioning regimen. Clin Transplant 19(6):840-7. (1.582;60/120;23/62;55/114;9/18)
97. Dar A PI, P. Goichberg C, V. Shinder C, A. Kalinkovich C, O. Kollet C, R. Margalit C, M. Zsak C, A. Nagler C, I. Hardan C, I. Resnick C, A. Rot C, T. Lapidot PI (2005) Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nature Immunology 6(10):1038-46 (IF 28.18)
98. S EladPI, A AckersteinC, M BitanC, M Y ShapiraC, I ResnickC, B GesundheitC, Y CohenC, O DissC, D BarakC, L DrayC and R Or (2006) A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation. Bone Marrow Transplant 37(8):757-62.
99. Igor B. Resnick PI, Memet AkerC, Michael Y. ShapiraC, Panagiotis D. TsirigotisC, Menahem BitanC, Ali Abdul-HaiC, Simcha SamuelC, Aliza AckersteinC, Benjamin GesundheitC, Irina ZilbermanC, Svetlana MironC, Luba YoffeC, Alex LvovichC, Shimon SlavinPI, Reuven OrPI (2006) Allogeneic stem cell transplantation for severe acquired aplastic anaemia using a fludarabine-based preparative regimen. British Journal of Haematology 133(6):649-54.
100. Tsirigotis P(C), Or R(C), Bitan M(C), Resnick IB(C), Samuel S(C), Ackerstein A(C), Elad S(C), Gesundheit B(C), Zilberman I(C), Miron S(C), Leubovic A(C), Slavin S(C) and Shapira MY(PI).. A non-myeloablative regimen in allogeneic stem cell transplantation (NST) from related and unrelated donors in elderly patients. Haematologica 2006 Jun;91(6):852-5.4.192; 12/62; 0
101. Miodosky M, Abdul-Hai A, Tsirigotis P, Or R, Bitan M, Resnick IB, Gesundheit B, Zilberman I, Ioffe L, Leubovic A, Slavin S, Shapira MY. (2006). Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate. Bone Marrow Transplant. 38(7):507-11
102. R. Eliashar, Igor Resnick, A. Goldfarb, J. Wohlgelernter, M. Gross (2006) Endoscopic surgery for sino-nasal invasive Aspergillosis in bone-marrow transplantation patients. The Laringoscope 2007; 117(1):78-81.
103. Kalinkovich A, Tavor S, Avigdor A, Kahn J, Brill A, Petit I, Goichberg P, Tesio M, Netzer N, Naparstek E, Hardan I, Nagler A, Resnick I, Tsimanis A, Lapidot T.(2006) Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells. Cancer Res. 2006; 66(22):11013-20
104. Or R(PI), Hadar E(C), Bitan M(C), Resnick IB(C), Aker M(C), Ackerstein A(C), Samuel S(C), Tsirigotis P(C), Gesundheit B(C), Slavin S(C) and Shapira MY(C). (2006). The safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation. Biol Bone Marrow Transplant;12:1295-301. 3.458; 5/19; 16/62; 0.
105. Or R, Gesundheit B, Resnick I, Bitan M, Avraham A, Avgil M, Sacks Z, Shapira MY. Sparing effect by montelukast treatment for chronic graft versus host disease: a pilot study. Transplantation. 2007 Mar 15;83(5):577-81.
106. Weiss L, Reich S, Zeira M, Or R, Resnick IB, Slavin S, Shapira M (2006) N-acetylcysteine mildly inhibits the graft vs leukemia effect but not the lymphokine activated cells (LAK) activity. Transpl Immunol. 2007 Apr;17(3):198-202.
107. Gesundheit B, Shapira MY, Ackerstein A, Resnik IB, Bitan M, Or R. (2006). A Patient with Progressive Multiple Myeloma Treated Successfully with Arsenic Trioxide after Allogeneic Bone Marrow Transplantation. Acta Haematol. 117(2):119-121
108. Resnick IB, Aker M, Tsirigotis P, Shapira MY, Abdul-Hai A, Bitan M, Gesundheit B, Amar A, Ackerstein A, Samuel S, Slavin S, Or R.Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen. Bone Marrow Transplant. 2007, 40(10):957-64.
109. Shapira MY, Tsirigotis P, Resnick IB, Or R, Abdul Hai A, Slavin S. (2007). Allogeneic hematopoietic stem cell transplantation in the elderly. Crit Rev Oncol Hematol. 2007;64(1):49-63. 4.490; 16/61; 0.
110. Shapira MY, Abdul Hai A, Tsirigotis P, Resnick IB, Or R, Slavin S. (2007). Hematopoietic stem cell therapy for malignant diseases. Annals of medicine. 4.594; 12/103; 0.
111. MY Shapira, P Tsirigotis, IB Resnick and R Or. (2007). Allogeneic bone marrow transplantation in the elderly, an emerging change in the transplantation field. Aging Health June 2007 3(3):275-277.
112. Spiegel A, Shivtiel S, Kalinkovich A, Ludin A, Netzer N, Goichberg P, Azaria Y, Resnick I, Hardan I, Ben-Hur H, Nagler A, Rubinstein M, Lapidot T. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34(+) cells through Wnt signaling. Nat Immunol. 2007 Oct;8(10):1123-31.
113. Tsirigotis P, Sella T, Shapira MY, Bitan M, Bloom A, Kiselgoff D, Levin M, Libster D, Hai AA, Gesundheit B, Or R, Slavin S, Resnick I. Peliosis hepatis following treatment with androgen-steroids in patients with bone marrow failure syndromes. Haematologica. 2007 Nov;92(11):e106-10.
114. Abdul-Hai A, Weiss L, Ergas D, Resnick IB, Slavin S, Shapira MY. The effect of high-dose thiotepa, alone or in combination with other chemotherapeutic agents, on a murine B-cell leukemia model simulating autologous stem cell transplantation. Bone Marrow Transplant. 2007 Nov;40(9):891-6.
115. Claudine Barkatz, David Mancuta*, Lola Weiss, Yisrael Reibstein, Gowda Basan, Gregory Elkin, Liat Mizrachi, Shimon Slavin and Igor B. Resnick. Mesenchymal Stem Cells from umbilical cord vein, placenta, and bone marrow demonstrate similar phenotype and immunosuppressive activity. Haematologica 2007; 92[suppl.2]:404. Abstract 1097
116. Lucotte G, Lagarde JP, and M. Kinali, C. Castellan, E. Sukarova, S. Jablonska, B. Tuysuz, I.B. Resnick (2007). Mutations of the NOGGIN and of the Activin A type I Receptor genes in Fibrodisplasia Ossificans Progressiva (FOP). Cenetic Counseling, vol. 18 (3): 349-352.
117. O. Gurevitch, S. Slavin, I. Resnick, S. Khitrin, A. Feldman. Vagima Y, Avigdor A, Goichberg P Folia Biologica (Praha) 55, 27-34 (2009)
118. Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, Caplan O, Saleh N, Efferth T, Marschall M, Wolf DG. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis. 2008; 46(9):1455-7.
119. Bitan M, Or R, Shapira MY, Resnick IB, Gesundheit B, Ackerstein A, Samuel S, Elad S, Slavin S. Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia. Bone Marrow Transplant. 2008; 41(1):69-78.
120. Resnick IB, Tsirigotis PD, Shapira MY, Aker M, Bitan M, Samuel S, Abdul-Hai A, Ackerstein A, Or R, Slavin S. ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients. Biol Blood Marrow Transplant. 2008 Apr;14(4):409-17
121. Amir G, Salant H, Resnick IB, Karplus R. Cutaneous toxoplasmosis after bone marrow transplantation with molecular confirmation. J Am Acad Dermatol. 2008; 59(5):781-4.
122. Shapira MY, Abdul-Hai A, Resnick IB, Bitan M, Tsirigotis P, Aker M, Gesundheit B, Slavin S, Or R.Alefacept treatment for refractory chronic extensive GVHD. Bone Marrow Transplant. 2009 Feb;43(4):339-43.
123. Gesundheit B, Shapira MY, Resnick IB, Amar A, Kristt D, Dray L, Budowski E, Or R. Successful cell-mediated cytokine-activated immunotherapy for relapsed acute myeloid leukemia after hematopoietic stem cell transplantation. Am J Hematol. 2009 Mar;84(3):188-90.
124. Elad S, Shapira MY, McNeal S, Or R, Garfunkel AA, Hirschhorn A, Bitan M, Resnick I, Benjamin G, Barasch A. Oral effects of nonmyeloablative stem cell transplantation: a prospective observational study. Quintessence Int. 2008; 39(8):673-8.
125. Cohen-Daniel L, Zakay-Rones Z, Resnick IB, Shapira MY, Dorozhko M, Mador N, Greenbaum E, Wolf DG. Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient. J Clin Virol. 2009 Feb; 44(2):138-40. Epub 2009 Jan 20.
126. Shapira MY, Resnick IB, Dray L, Aker M, Stepensky P, Elad S, Gesundeheidt B, Samuel S, Or R.A new induction protocol for the control of steroid refractory/dependent acute graft versus host disease with alefacept and tacrolimus. Cytotherapy. 2009; 11(1):61-7.
127. Vagima Y, Avigdor A, Goichberg P, Shivtiel S, Tesio M, Kalinkovich A, Golan K, Dar A, Kollet O, Petit I, Perl O, Rosenthal E, Resnick I, Hardan I, Gellman YN, Naor D, Nagler A, Lapidot T. MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization. J Clin Invest. 2009 Mar;119(3):492-503
128. Kedmi M, Resnick IB, Dray L, Aker M, Samuel S, Gesundheit B, Slavin S, Or R, Shapira MY. A retrospective review of the outcome after second or subsequent allogeneic transplantation. Biol Blood Marrow Transplant. 2009 Apr; 15(4):483-9.
129. B Gesundheit, E Budowski, M Israeli, MY Shapira, IB Resnick, R Bringer, Y Azar, S Samuel, L Dray, A Amar, D Kristt and R Or. Assessment of CD4 T-lymphocyte reactivity by the Cylex ImmuKnow assay in patients following allogeneic hematopoietic SCT. Bone Marrow Transplantation (2009), 1–7.
130. Tsirigotis P, Dray L, Resnick IB, Ackerstein A, Gesundheit B, Elad S, Or R, Shapira MY. Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma. Ann Hematol. 2009 Aug 20. [Epub ahead of print]
Case Reports
131. R.Pomo C, I. Reznick C, U.Dimita C (1994). Un caso raro di reinfezione da rosolia in gravidanza . [A rare case of roseola in pregnancy] Il Pediatra, [Article in Italian].
132. Oleg Togoev C, Svetlana Tverskaya C, Oleg Evgrafov C, Natalia Vasserman C, Irena Shagina C, Pachanov ED C, Igor B. Resnick PI (2001). A case of the familial predisposition to malignancies associated with heterozygote carriage of 657del5 mutation in NBS1 gene. Pediatriia; N4: 78-80*
133. Bitan M C, Or R C, Shapira MY C, Mador N C, Resnick IB C, Saleh N C, Weinberger KM C, Samuel S C, Schechter E C, Slavin S C, Wolf DG C (2004). Early-onset Guillain-Barre syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation. Clin Infect Dis. 39(7):1076-8. (5.393;14/114;3/41;9/84;0)
134. Resnick IB C, Gomori JM C, Kiselgoff D C, Lossos A C, Zilberman I C, Miron S C, Bitan M C, Or R C, Slavin S C, Shapira MY C (2004). Spinal epidural lipomatosis following haploidentical allogeneic bone marrow transplantation for non-Hodgkin lymphoma. Clin Transplant.8(6):762-5 (1.582;43/141;12/18;0)
135. Gesundheit B, Resnick IB. Regurgitation of esophageal mucosa. Mayo Clin Proc. 2007 Aug; 82(8):907.
136. Polina Stepensky , Shoshana Revel-Vilk , Michael Weintraub , Elisha Waldman, Mira Harit , Dina Averbuch , Jeffrey Weinberger , Reuven Or, Resnick Igor. Combination of umbilical cord blood with bone marrow from two months sibling as a lifesaving bone marrow transplantation for very severe aplastic anemia. Bone Marrow Transplant 2008 Oct; 42(8):563-4.
137. Polina Stepensky, Shoshana Revel-Vilk, Orly Yehuda-Gafni, Bella Mali, Igor B. Resnick, Michael Weintraub. Isolated CNS granulocytic sarcoma and meningeal myeloid leukemia: successful treatment without radiotherapy. IMAJ 2008, Nov (accepted).
138. Igor Resnick, Polina Stepensky, Gregory Elkin, Claudine Barkatz, Olga Gurevich, Tatyana Prigozhina, Eli Pikarsky, Elisha Waldman, Avraham Amar, Simcha Samuel, Michael Shapira, Michael Weintraub, Reuven Or. Mesenchymal stromal cells (msc) for improvement of hematopoietic engraftment. Bone Marrow Transplant. 2009 Jul (accepted)
139. Polina Y. Stepensky, Reuven Or, Michael Y Shapira, Shoshana Revel-Vilk, Jerry Stein, and Igor B. Resnick. Second bone marrow transplantation for patients with thalassemia: risks and benefits. Haematologica 2009 Dec, Issue 94/12 (accepted).
140. Polina Stepensky, Elisha Waldman, Natalia Simanovsky, Iris Fried, Shoshana Revel-Vilk, Igor B. Resnick, Michael Weintraub. Isolated CNS Vasculitis: Unusual Presentation Of Relapsed Ewing Sarcoma. Pediatric Blood & Cancer 2009 Jul (accepted).
Reviews, Tutorials, Consensus and State-of-the-Art Papers
141. Reznik IB (1980) [Developmental anomalies of the trachea and bronchi]. Ther Arkh.; 52(12):129-34. Review. [Article in Russian].
142. Resnick IB (1984). [Prostanoids as allergic reaction mediators (a review).] Immunologia; 4: p. 2-8. Russian, English abstract. * (2;2)
143. Resnick IB (1990). Treatment of childhood asthma. A clinical lecture. Vrach (Physician) N3: 10-12. [Invited article]*
144. Resnick IB (1992). Childhood asthma: diagnosis and classification. Pulmonologia,N3: 13-17 [Invited article] *
145. F
.S.Rosen, R.J.P.Wedgwood, M.Eibl, … I.B. Reznik et al. (1995). Primary Immunodeficiency Diseases. Report of a WHO Scientific Group. -Report of a WHO Scientific Group. Clinical and Experimental Immunology, vol.99, Suppl.1.-25 (2.347;48/114;10;10)
146. I.Resnick (1996). Primary immunodeficiencies: a state of the art. Pediatria N2: 3-13 [Invited article]
147. Rosen F.S., R.J.P. Wedgwood, M.Eibl, A.Fischer, F.Aiuti, L.Notarangelo, T.Kishimoto, I.B.Reznick, L.Hammarstrom, R.Seger, H.Chapel, R.A. Thompson, M.D.Cooper, R.S.Geha, R.A.Good, T.A. Waldmann (1997). Primary Immunodeficiency Diseases. Report of a WHO Scientific Group. Clinical and Experimental Immunology; 109, Suppl. 1: 1-28.(2.347;48/114;19;19)
148. Consensus report of expert group. Bronchial asthma in children: A treatment strategy and prophylaxis (Journal version prepared by Prof. N.A. Geppe and Prof. I.B.Resnick) (1998). Russian Journal of Medicine; 6,2:3-48 [Invited article] *
149. I.Resnick (1998). Immunodeficient disorders of genetic origin: a new view of the problem. Russian J Medicine; 6, 9-16 [Invited article] *
150. I.Resnick(1998). The genetic background of bronchial asthma. Allergologia; 1: 7-14 [Invited review article] *
151. I.Resnick (1998). Introduction in basic immunology for physicians: lecture I. Allergologia, 3: 32-37 [Invited article] *
152 I.B.Resnick (1998) Introduction in basic immunology for physicians: lecture II. Allergologia; 4: 32-37 [Invited article] *
153. Resnick IB (1999). [Introduction in basic immunology for physicians: cytokine receptors (lecture III)] Allergologia, 2: 32-37. [Invited article] *
154. Rosen F.S., M.Eibl, C.Roifman, A.Fischer, J.Volanakis, F.Aiuti, L.Notarangelo, T.Kishimoto, I.B.Resnick, L.Hammarstrom, R.Seger, H.Chapel, M.D.Cooper, R.S.Geha, R.A.Good, T.A. Waldmann, R.J.P. Wedgwood (1999). Primary Immunodeficiency Diseases. Report of an IUIS Scientific Committee. Clinical and Experimental Immunology; 118 (Suppl. 1): 1-28 (2.347;48/114;7;7)
155. Chapel, H., Geha, R., Rosen F. from IUIS PID Classification Committee: F. S. Rosen (chairman), M. Eibl, C. Roifman, A. Fischer, L. Notarangelo, T. Kishimoto, I. Resnick, L. Hammarstrom, R. Seger, H. Chapel, J. Volkanakis, M. D. Cooper, R. S. Geha, R. A. Good, J. Puck and T. Waldmann (2003). Primary immunodeficiency diseases: an update. Clinical & Experimental Immunology 132 (1), 9-15. (2.347;48/114;18;18)
156. Slavin S, Morecki S, Weiss L, Shapira MY, Resnick I, Or R. (2004) Nonmyeloablative stem cell transplantation: reduced-intensity conditioning for cancer immunotherapy--from bench to patient bedside. Semin Oncol; 31(1):4-21. (4.733;16/120;0)
157. Resnick IB, Shapira MY, Slavin S. Nonmyeloablative Stem Cell Transplantation and Cell Therapy for Malignant and Nonmalignant Diseases (2005). Transplant Immunology 14(3-4):207-19.
158. Shapira MY (PI), Resnick IB (C), Tsirigotis P (C), Slavin S(C). (2006). Biological response modifiers as adjuncts to stem cell transplantation. Expert Opin Biol Ther; 6:467-483. 2.705; 38/140, 0.
159. Resnick IB Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome Supportive Care in Cancer. JSCC 2009 Aug (JSCC-D-09-00265).
Proceedings, Refereed Conference Papers
160. Torubarova NA, Resnick IB (1977). [Reactions of pediatric patients with acute leukemia and aplastic anemia for repeated blood transfusions.] Proceedings of National conference on transfusiology and hematology in pediatrics. Baku: 67-70. [in Russian].
161. Sokolova TS, Zakhidov YV, Zgukovski AM, Resnick IB (1981) [Some questions of the symptomatic treatment of bronchial asthma in children.] Proceedings of the VII Symposium of Pediatricians of Socialist Countries, Moscow [in Russian].
162. Sokolova TS, Resnick IB (1981). [To the theory of beta-2-adrenergic blockade in bronchial asthma in children.] Proceedings of the VII Symposium of Pediatricians of Socialist Countries, Moscow: 87-88 [in Russian].
163. Karachentseva TV, Bespalko NN, Resnick IB (1981) [Use of histamine electrophoresis in asthma and atopic dermatitis in children.] Proceedings of V Congress of Georgian Pediatricians. Tbilisi: 60-62 [in Russian].
164. Sokolova TS, Stepanova II, Zakhidov YV, Resnick IB . (1981) [Changes in mediators of allergy and pharmacological treatment of pediatric asthma.] Proceedings of V Congress of Georgian Pediatricians. Tbilisi: 56-59 [in Russian].
165. Balabolkin II, Botvinjeva VV, Bakanov MI, Resnick IB (1984) [Several aspects of patogenesis and treatment of atopic diseases in childhood.] Proceedings of III Congress of Pediatricians of Kazakhstan. Vol 3. Alma-Ata: 2-3 [in Russian].
166. Balabolkin II, Sereda EV, Resnick IB (1987) [Modern aspects of pediatric asthma.] Novel approaches to treatment of asthma with Zaditen (ketotifen). Proceeding book, Moscow: p. 4-8. [Article in Russian].
167. Galkina EV, Kondratenko IV, Resnick IB (2001) Microbacterial Infection in Primary Immune Deficiency: Medical Immunology, vol. 3(2): 194-95 [in Russian](oral presentation)
168. Kondratenko IV, Kouznetzova MA, Konopleva EA, Pashanov ED, Bologov AA, Resnick IB (2001) Diagnostics and treatment of patients with primary immune deficiency at the Russian Children’s Hospital, Moscow. Medical Immunology, vol. 3(2): 196-97 [in Russian](oral presentation)
Research Abstracts, Oral And Poster Presentations
169. Sokolova TS, Stepanova II, Lemeshkina VS, Resnick IB. Comparison of different bronchodilators in asthmatic children. . II-nd Congress of Kazakhstan Pediatricians. Abstracts. Alma-Ata 1979: p. 133-4.
170. Resnick IB. The place of prostaglandins in development of bronchial constriction in childhood asthma. Immune reactivity in pathophysiology. Kiev-Vinnitsa 1979. Abstract No 91.
171. Zakhidov YV, Safonova TY, Volkov LD, Resnick I. Associations between metabolism of unsaturated fatty acids and prostaglandins in asthma. II Congress of Kazakhstan Pediatricians. Abstracts. Alma-Ata 1979: p. 112.
172. Resnick IB, Sokolova TS, Markov CM. [Place of prostaglandins in hemodinamic changes which accompanied acute asthma attack.] Prostaglandins and hemodinamics (Nationwide symposium). Abstracts. Erevan 1980.
173. Sokolova TS, Resnick IB, Markov CM. [Plasma prostaglandin level changes in asthmatic children.] Abstracts of the II Congress of Uzbekistan pediatricians. Tashkent 1980. Russian
174. Resnick IB. [Prostaglandins and poly-unsaturated fatty acids in pediatric asthma.] Abstracts of the II Congress of Uzbekistan pediatricians. Tashkent 1980. Russian.
175. Sokolova TS, Botvinjeva VV, Stepanova II, Resnick IB. [Immune reactivity and inflammatory mediators in pediatric atopic diseases.] IV congress of pediatricians of BSSR: Lungs, GI diseases and allergy in childhood. Abstracts book. Minsk 1981. Russian.
176. Sokolova TS, Stepanova II, Botvinjeva VV, Resnick IB . [Modern view on pathogenesis and treatment of allergic (atopic) diseases.] Clinical and experimental allergology and immunology. Abstract book. Kaunas 1981. Russian
177. Resnick IB. Place of primary prostaglandins (PG) in asthma and approaches to the treatment. Abstracts of XI National Congress of Pediatricians. Moscow 1982: 2. Russian.
178. Yurkov YA, Sokolova TS, Bakanov MI, Resnick IB . Changes in cyclic nucleotides system and prostaglandin’s production in pediatric asthma and possibilities of their correction. Cyclic nucleotides. Abstract Book of the IV National Symposium. Minsk 1982: 86-87.
179. Jazdovski VV, Resnick IB, Alekseev LP, Uljanov LI . [HLA phenotype and associated characteristics of immune status in atopy.] Modern Immunotherapy Methods. Abstract book. Moscow-Tashkent: 1984. Russian.
180. Torubarova NA, Alymkulova E, Resnick IB. [Place of PBMC analysis with monoclonal antibodies panel in different diseases.] Modern Immunotherapy Methods. Abstract book. Moscow-Tashkent: 1984. Russian.
181. Resnick IB, Popov KM, Bulgarina TV, Severin ES. [Defects in regulation of adenilat cyclase activity of PBSC in asthma.] Cyclic nucleotides and enzyme reaction regulation. V National meeting. Abstract book. Ryazan 1985. p.2
182. Sokolova TS, Nurdolotova S, Resnick IB . The markers of atopy in pollinosis and their role in preventive therapy. XII Congress of Estonia Pediatritians. Book 2. Tallinn, 1985. Abstract. Russian.
183. Alymkulova EY, Resnick IB. Bloor T cells characteristics in pediatric asthma. XII Congress of Estonia Pediatricians. Book 2. Tallinn, 1985. Abstract.
184. Resnick IB, Alymkulova ED. [PBMC characteristics in childhood asthma (analysis with monoclonal antibodies).] V International Congress in Allergy-Clinical Immunology of Kazakhstan and Middle Asian Republics. Alma-Ata 1986. Russian.
185. Resnick IB. Mistakes analysis in interpretation of immune status of patients with allergic disorders. Republican meeting of junior researches. Abstract book. Tbilisi, 1986: 78 (Russian)
186. Resnick IB, Voronov VA, Vengerov YY. [Immunological monitoring of an allergen-specific desensitization therapy of atopic pediatric asthma.] VI Congress of Georgian Pediatric Society. Tbilisi 1987; vol. 2. Russian.
187. Resnick IB. Cell metabolism disregulation in childhood asthma and it pharmacological correction. Actual problems of pediatric allergy. Abstract book (Kobuleti), 1987. Russian.
188. Batyrkhanov S, Gorelova JYu, Orlova OI, Resnick IB. [Recurrent obstruction characteristic in pediatric purulent lung disease.] Congress of Kyrgyzstan Pediatric Society. Abstracts book, 1991. Russian
189. Resnick IB, N.A.Torubarova. Blood B-cells immunophenotype in children with total antibody deficiency syndromes. Ibidem, Abstract N92
190. Resnick IB, M.A.Ulanova O.I.Orlova. IgG subclass deficiency in children with chronic ling diseases. Meeting of the European Group for Immunodeficiencies Lugano-Switzeland. 1992. Abstract N68
191. Resnick IB, V.K.Tatochenko. Asthma in children and toddlers. XV Congress of EAACI. Paris-France. 1993 Abstract N 1279
192. Resnick IB, J.Yu Gorelova. Effect evaluation of oral bronchodilators in bronchial obstruction in early childhood. Abstract N269, 1992.
193. Resnick IB, V.K.Tatochenco, N.F.Dorochova, N.A.Torubarova, J.Yu.Gorelova. Prognosis and early preventive treatment of recurrent wheezing and asthma. Poster abstract 4, Annual Meeting of the ESPACI. Potsdam Germany.1993
194. Resnick I. Wheezy bronchitis recurrence prediction in young children with Broncho-Munal. First European Pediatric Congress. Abstract book. Paris,France,1994,N15
195. I.Resnick, R.Pomo, U.Dimita. Two rare cases of roseola reinfection during pregnancy (special and general considerations). Abstract. "Pediatric allergy and Clinical Immunology". Moscow, 1994, p.101 (poster presentation).
196. O.Danhaive, I.Reznick, U.Dimita. Epidemiology of systemic fungal infections during a six-year period in a neonatal intensive care unit- -Abstract book of international meeting "Pediatric allergy and Clinical Immunology". Moscow 1994:91(poster presentation)
197. I.Resnick. Asthma severity assessment. Abstract. "Pediatric allergy and Clinical Immunology". Moscow, 1994, p.47-48 (oral presentation)
198. I.Resnick, A.Stcherbina G.Kosmiadi, J.Kulak. Some Findings in Bronchoalveolar Lavage in Children with Asthma. Abstract. Pediatric Allergy and Immunology (Official Publication of the European Society of Pediatric Allergy and Clinical Immunology). 1995 Suppl.N8.
199. I.Kondratenko, I.Resnick, A.Bologov, G.Kovalev et аl. Immunomorphogical picture of lymphatic nodes from children with persistent lymphadenopatia and hyperimmunoglobulinemia. Progress in immunodeficiency V.I.Caragol, T.Espanol, G.Fontan, N.Matamoros eds. Springer-Verland Iberica, S.A.Barcelona 1995 (poster presentation)
200. I.Resnick, G.Kovalev I.Kondratenko A.Bologov. Leukocyte Adhesion deficiency (LAD) syndrome. Ibid.,1995 (poster presentation)
201. L.Gomez M.Yartsev I.Kondratenko, I.Reznik. Updating the Russian Registry of Primary Immunodeficiency. Final Program and Abstract. VIII Meeting of the European Society for Immunodeficiencies. Goteborg, 1996, #3 (poster presentation)
202. A.Bologov, I.Kondratenko, I.Resnick. The Unusual Clinical Manifestation in IgA Deficiency. Ibid., #81 (poster presentation)
203. I.Resnick, V.Bobrynina, S.Tverskaya, G.Kovalev, I.Kondratenko, A.Bologov, O.Evgrafov. Two Mutations in BTK Gene in Two Unrelated Patients with X-linked Agammaglobulinemia. Ibid., #60 (poster presentation)
204. M.Fiorini, S.Gilliani, P.Mella, L.D.Notarangelo, F.Boe, G.Loffredo, O.Parolini, V.Poggi, F.Porta, I.B.Reznick, A.G.Ugazio, G.Wengler, A.Fasth. Identification of Nine Novel mutation in WASP gene in patients with WAS or XLT and Demonstrations of an Affected Male Fetus Using SSCP/HD Screening Method. Ibid., #44 (poster presentation)
205. J.Levy, T.Espanol, C.Thomas, A.Fischer, P.Tovo, P.Bordigoni, I.Reznik, A.Fasth, M.Baer, L.Gomez, E.Sanders, M.Tabone, D.Plantaz, A.Etzioni, V.Monafo, L.Hammarsrom, L.Notarangelo. Clinical Manifestations of 43 European Patients with CD40L Deficiency. Ibid., #38 (poster presentation)
206. I.Resnick, J. Kulak, AJ Usacheva, AJ Stcherbina, GI Kovalev, VP Nazgimov. The pathological markers of an airways inflammation in pediatric asthma. Allergic diseases in childhood. Moscow 1996, p.114 (abstract).
207. G.Kovalev, I Resnick, E.Pashanov, R.Sorensen. Transient Leukocyte Adhesion Deficiency with Mucocutaneous Candidiasis and Sinusitis. Abstract. J. Allergy Clin Immunology 1997, 99,1: part 2.
208. G.Kovalev I.Kondratenko A.Bologov, M.Kouznetsova, A.Usacheva, R.U.Sorensen, I.B.Resnick. A Syndrome of Persistent Lymphadenopathy, Splenomegaly and Hyperimmunoglobulinemia of Unknown Driline in Russian Children. J.All.Asthma Clin.Immunol.1997, 99 (1),part 2,S341, abstract 1392.
209. S.Tverskaya, V.Bobrynina, I.Reznik, A.Chuhrova, G.Kovalev, I.Kondratenko, O.Evgrafov. Molecular diagnosis of X-linked agamma-globulinemia - Cesco-Slovenska Pediatrie, 1997, 52(7):572 (poster presentation)
210. I.Reznick, J.Kulak, I.Konakova. Effect of low and high doses of flunisolide in modarate and severe childhood bronchial asthma- Europ.J.Allergy Clinical Immunol. 1997, 52, 37 (Suppl.), p. 144 (Abstract)
211. E.Pashanov, E.Haddad, J.-L.Casanova, I.Resnick, Fisher A. Treatment of EBV B cell Lymphoproliferative Disorder with Anti-IL6 Monoclonal Antibodies--J.Clin. Microbiol. & Inf. 1997, Vol.3, Suppl.2, P1436, p.355
212. S.Lacroix-Desmazes, I.Resnick, L.Mouthon, S.V.Kavery, M.D.Kazatchkine -Defective self-reactive antibody repertoire of serum IgM in patients with the hyper-IgM syndrome- The Immunologist 1998, Nov.: Suppl .10th International Congress of Immunology. Abstracts.
213. E.A.Konoplyova, I.V.Kondratenko, I.M.Molotkovskaja, A.M.Sapozhnikov, N.A.Zelenova, I.B.Resnick. Description of molecular, cellular, and humoral immune defects in patients with autoimmune lymphoproliferative syndrome. Molecular Immunology 1998, vol.35, 11-12: 752 (oral presentation)
214. I.B.Resnick, I.V.Kondratenko, A.A.Bologov, L.Gomez. Two familial cases of Purtilo syndrome. Molecular Immunology 1998, vol.35, 11-12: 751
215. I.B.Resnick, I.V.Kondratenko, L.D.Notarangelo, Luigi D.Notarangelo. Primary immunodeficiency with microcephalia: report of eight cases. Molecular Immunology 1998, vol.35, 11-12: 743 (poster presentation)
216. I.V.Kondratenko, L.Gomez, S.M.Nverskaya, I.B.Resnick. Two novel mutations in X-linked agammaglobulinemia. Molecular Immunology 1998, vol.35, 11-12: 721
217. IV Kondratenko, M.Kouznetsova and I.Resnick - Unusual Course of Combined Immunodeficiency: Case Report. Abstract. Clinical Immunology 1999.
218. M. Kouznetsova, I. Kondratenko, I.Resnick. Fatal Encephalitis in Patient with CD40 Ligand Deficiency. Abstract. - Clinical Immunology 1999, March (abstract)
219. S.Lacroix-Desmazes, I.Resnick, D.Stahl, L.Mouthon, S.V.Kavery, M.D.Kazatchkine. Defective self-reactive antibody repertoire of serum IgM in patients with the hyper-IgM syndrome. J. Autoimmunity 1999, April: Supplement: Abstracts of 2nd International Congress on Autoimmunity (poster presentation).
220. Resnick IB, Togoev O, Evgrafov O, Kondratenko I, Pachanov E, Maschan A, Roumiantsev A. Whether 657del5 Nijmegen breakage syndrome mutation carrier status associated with predisposition to malignancies. IX Meeting of the European Society for Immunodeficiencies. Abstract book, 2000: p.148 (poster presentation)
221. Resnick IB, Kondratenko I, Togoev O, Evgrafov O, Cerosaletti KM, Concannon P. Nijmegen breakage syndrome in Russia: clinical characteristics and mutation analysis in eight unrelated families. IX Meeting of the European Society for Immunodeficiencies. Abstract book, 2000: p.147 (poster presentation).
222. Konopleva EA, Kondratenko IV, Resnick I.B. Autoimmune phenomena in Wiscott-Aldrich syndrome. IX Meeting of the European Society for Immunodeficiencies. Abstract book, 2000: p.146 (poster presentation).
223. E.Pachanov, E.Skorobogatova, D Balashov, P.Trakhtman, M. Yurlova, O.Blagonravova, I. Shypitsina, A.Maschan, I.Resnick. Resistant autoimmune hemolysis following T cell – depleted bone marrow transplantation in T-B-SCID patient. IX Meeting of the European Society for Immunodeficiencies. Abstract book, 2000: p.139.
224. I.Kondratenko, E.Konopleva, I.Molotkovskaya, Frederic Rieux-Laucat, Igor Resnick. Autoimmune Lymphoproliferative Syndrome: report on 21 patients. IX Meeting of the European Society for Immunodeficiencies. Abstract book, 2000: p.4 (poster presentation).
225. Resnick IB, Kondratenko I, Togoev O, Vasserman N, Shagina I, Evgrafov O, Tverskaya S, Cerosaletti KM, Concannon P. Nijmegen breakage syndrome in Russia: clinical characteristics and mutation analysis in eight unrelated families. Workshop on Nijmegen breakage syndrome (Abstracts) 2000: p. 9 (oral presentation)
226. Resnick IB, Tverskaya S, Evgrafov O, Togoev O, Kondratenko I, Pachanov E, Maschan A, Roumiantsev A. Association of the 657del5 Nijmegen breakage syndrome mutation with lymphoid tissue malignancies in childhood. International Workshop on Nijmegen breakage syndrome (Abstracts) 2000: p.31 (oral presentation)
227. Slavin S, Shapira MY, Resnick I, Zilberman I, Ackerstein A, Samuel S, Or R. Clinical application of non-myeloablative stem cell transplantation for the treatment of malignant and non-malignant diseases. 7th Congress of the Asian Society of Transplantation (CAST). New Delhi, India. November 21-25, 2001.
228. Kondratenko IV, Sidorenko IV, Karaulov AV, Ilyina NI, Latysheva TV, Prodeus AP, Scherbina AY, Paschenko OE, Yurasova AS, Konopleva EA, Usacheva AY, Bologov AA, Kouznetsova MA, Pachanov ED, Sigbatullina FI, Setdikova N, Resnick IB. Registry of the primary immunodeficiencies. Russian Society of Allergy and Clinical Immunology – “Days of Immunology in St. Petersburg”, St. Petersburg 2002, abstract # 176 (oral presentation)
229. Sidorenko IV, Kondratenko IV, Resnick IB. Effectiveness and safety of IVIG (OctagamTM) in primary immune deficiencies. Ibid, abstract #177.
230. Paschenko OE, Kouznetsova MA, Yurasova AS, Sidorenko IV, Pachanov ED, Resnick IB, Kondratenko IV. Spectrum of infections in the primary immunodeficiencies. Ibid, abstract #178 (oral presentation).
231. Resnick IB, Konopleva EA, Kouznetsova MA, Pachanov ED, Bologov AA, Vertlina IL, Tverskaya SM, Evgrafov OI, Kondratenko IV. Our first experience in prenatal diagnostics of several primary immunodeficiencies. Ibidem, abstract #406 (oral presentation)
232. Abraham Avigdor, Shimon Schwartz, Polina Goichberg, Isabelle Petit, Izhar Hardan, Igor Resnick, Shimon Slavin, Arnon Nagler and Tsvee Lapidot (2004). Membrane Type 1-Matrix Metalloproteinase is Directly Involved in G-CSF Induced Human Hematopoietic Stem and Progenitor Cell Mobilization (with the Hematology and BMT Dept. Chaim Sheba M.C. Tel-Hashomer, Immunology Dept., and The Weizmann Inst. of Science, Rehovot) The American Society of Hematology 46th Annual Meeting. Blood, 2004 vol. 104(11/1) abstract # 2675 (poster board).
233. Shimon Slavin, Reuven Or, Memet Aker, Michael Y Shapira, Igor B Resnick, Menachem Bitan, Svetlana Miron, Irina Zilberman, Simcha Samuel, Yael Gelfand, Corinne Nabet, Osnat Isaacs, Aliza Ackerstein and Shoshana Morecki (2004). Treatment of Resistant Leukemia by rIL-2 Activated NK Cells in Recipients of HLA Matched and Haploidentically Mismatched Stem Cell Allografts While Avoiding GVHD. The American Society of Hematology 46th Annual Meeting. Blood, 2004 vol. 104(11/2) abstract #5180.
234. Resnick I. The Soreq Accident: Treatment with Cytokines and Stem Cell Transplantation (2005). EBMT Consensus Conference on European Preparedness for Haematological and other Medical Management of Mass Radiation Accidents (invited oral presentation).
235. MY Shapira, IB Resnick, M. Bitan, PD Tirigotis, M Aker, B Gesundheit, L Yoffe, I Zilberman, S Miron, A Levovic , S Slavin, R Or. Alefacept treatment for chronic extensive graft-verss-host diseas. Bone Marrow Transplantation 2007 Apr;39(1):s117
236. P Tirigotis, R Or, MY Shapira, M Bitan, S Samuel, Y Polyansky, A Ackerstein, B Gesundheit, S Slavin, IB Resnick. Influence of graft composition on the incidence of acute and chronic graft-versus-host disease after non-myeloablative allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplantation 2007 Apr;39(1):s91
237. Michael Y Shapira, Igor B Resnick*, Reuven Or, Shoshanna Morecki, Yael Gelfand, Osnat Eizik, Memet Aker, Menachem Bitan, Irina Zilberman, Benjamin Gesundheit, Simha Samuel, Lilian Dray, Aliza Ackerstein , Shimon Slavin (2006) Irradiated lymphokine-activated killer cells (iLAK): a safe tool for immunotherapy after haploidentical stem cell transplantation (HSCT): a Pilot Report Abstract, EBMT – 2007
238. IB Resnick, MY Shapira, B Gesundheit, M Bitan, D Rund, I Zilberman, S Miron, L Yoffe, A Lvovitch, O Zelig, N Manny, R Or, S Slavin. Effective treatment of severe pseudo-autoimmune hemolytic anaemia after allogeneic hematopoietic stem cell transplantation using plasmapheresis-rituximab-ATG-cyclophosphamide containing protocol. Bone Marrow Transplantation 2007 Apr;39(1):s292
239. MY Shapira, AI Bloom, R Or, IB Resnick, M Aker, M Bitan, I Zilberman, S Miron, L Yoffe, A Levovic, S Slavin, A Verstandig. A comparison between 2 intra-arterial treatment protocols for hepatic steroid resistant/dependent graft-versus-host disease. Bone Marrow Transplantation 2007 Apr;39(1):s112
240. MY Shapira, P. Tsirigotis, R Or, IB Resnick, B Gesundheit, S Slavin (2006) Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia Abstract # 3038 Poster Board /Session #267-III Blood 108(11):1:863a
241. MY Shapira, R Or, IB Resnick, S Samuel, B Gesundheit, S Slavin (2006) Enhancement of Hematopoietic Stem Cell Engraftment and Graft vs. Leukemia Effect Induced by Matched and Haploidentically Mismatched Allograft Using Multi-Donor Stem Cell Transplantation (MDT). Abstract # 3633 Poster Board /Session # 892-III Blood 108(11):1:1046a
242. B Gesundheit, Y Azar, R Bringer, S Steinberg-Prop, M Israeli, M Y Shapira, IB Resnick, S Samuel, S Slavin, R Or (2006) Assessment of the Immune Reconstitution by Cylex ImmuknowTM Assay in Patients after Allogeneic Stem Cell Transplantation Abstract # 3219 Poster Board /Session # 448-III Blood 108(11):1:919a
243. Slavin S, Shapira MY, Resnick IB, Bitan M, Aker M, Samuel S, Morecki S, Or R (2006) Amplification of Graft vs Malignancy (GVM) Effects by Using Intentionally Mismatched Donor Lymphocytes while Avoiding Graft-vs-Host Disease in Conjunction with Haploidentically Mismatched Stem Cell Allografts in Patients with Hematological Malignancies. Abstract #5157 Blood, 108(11):2:379b
244. MY Shapira, P. Tsirigotis, R. Or, IB Resnick, M Bitan, B Gesundheit, S Slavin (2006) Transplantation from Related and Unrelated Donors in Elderly Patients – Equal Toxicity and Survival. Abstract # 5255 Blood 108(11):2:405b
245. C Barkatz, D Mancuta, L. Weiss, I Rebstein, B Kurkalli, G Elkin, L Mizrachi, S Slavin, O Gurevitch, I Resnick. Mesenchymal stem cells from umbilical cord vein, placenta, and bone marrow demonstrate similar phenotype and immunosuppressive activity which is not mediated by apoptosis. Haematologica 2007; 92 (s1) 404
246. MY Shapira, AI Bloom, R Or, IB Resnick, M Aker, M Bitan, I Zilberman, S Miron, L Yoffe, A Levovic, S Slavin, A Verstandig. Intra-arterial treatment for steroid resistant/dependent graft-versus-host disease. Bone Marrow Transplantation 2007 Apr;39(1):s115-6
247. MY Shapira, Abdul Hai, IB Resnick, M Bitan, PD Tsirigotis, M Aker, B Gesundheit, L Yoffe, I Zilberman, S Miron, S Slavin, R Or. The effect of alefacept treatment on lymphoid subpopulation in patients with chronic extensive graft-versus-host disease. Bone Marrow Transplantation 2007 Apr;39(1):s117-8
248. MY Shapira, IB Resnick, T Stamminger, T Efferth, O Kaplan, M Marshall,DG Wolf Artesunate as potent anti-CMV agent in patient after mismatched haematopoietic cell transplantation. Bone Marrow Transplantation 2007 Apr;39(1):s167-8 (IBR & MYS put equal contribution)
249. MY Shapira, PD Tsirigotis, IB Resnick, M Bitan, S Samuel, S Elad, B Gesundheit, R Or, S Slavin (2007) Transplantation from related and unrelated donors in elderly patients shows equal toxicity and survival. Abstract, EBMT meeting 2007. Abstract book (poster)
250. MY Shapira, AI Bloom, R Or, IB Resnick, M Aker, M Bitan, S Slavin, A Verstandig. Treatment of steroid refractory graft vs host disease by inta-arterial infusion. Haematologica 2007; 92 (s1) 216 (poster)
251. MY Shapira, IB Resnick, P Tsirigotis, M Aker, M Bitan, B Gesundheit, S Slavin, R Or. Treatment of chronic extensive graft versus host disease with alefacept. Haematologica 2007; 92 (s1) 216 (poster)
252. MY Shapira, IB Resnick, B Gesundheit, M Bitan, S Samuel, L Dry, Y Vercolevsky, S Slavin, R Or. Multi-donor stem cell transplantation (MTD) from haploidentical mismatched donors engraftment safely data. Haematologica 2007; 92 (s1), 170
253. MY Shapira, AI Bloom, R Or, IB Resnick, M Aker, M Bitan, S Slavin, B Gesundheit, A Verstandig. Two intra-arterial treatment protocols for steroid refactory graft vs. host disease of the liver. Haematologica 2007; 92 (s1) 356
254. IB Resnick, P Tsirigotis, MY Shapira, M Bitan, I Zilberman, S Miron, L Yoffe, A Lvovitch, R Or, S Slavin. ABO incompability is associated with increased non-relapse and GvHD related mortality in patients with haematologocal malignancies treated with a reduced-intensity regimen: a single-centre experience of 221 patients. Bone Marrow Transplantation 2007 Apr;39(1):s41 (oral presentation on EBMT 2007)
255. IB Resnick, I Zilberman, PTsirigotis, M Aker, MY Shapira, M Bitan, B Gesungheit, A Amar, A Ackerstein, S Samuel, S Slavin, R Or. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine based regimen. Haematologica 2007; 92 (s1) 132 (oral presentation on EHA 2007)
256. Prigozhina T, Elkin G, Slavin S, Resnick IB. Visualization of DLI-induced cytotoxicity in complete chimeras (2008) EBMT 2008 41(1):s199. (Poster).
257. M.Y. Shapira, L. Dray*, I.B. Resnick, P.D. Tsirigotis, B.Gesundeheidt , R. Or. Prophylactic and therapeutic post autologous transplant rituximab therapy. EBMT 2008 41(1):s166. (Poster)
258. M.Y. Shapira*, B. Abu-Ziad, I.B. Resnick, B. Gesundeheidt , L.Drey, S. Samuel, R. Or. A comparison between two conditioning protocols for autologous transplantation in multiple myeloma. EBMT 2008 41(1):s185 (poster).
259. M.Y. Shapira*, I.B. Resnick, B. Gesundheit, A. Ackerstein, L.Drey, M. Bitan, Y. Verkholevsky, S. Slavin, R. Or. Faster platelet recovery with lower platelet consumption in a non-myeloablative stem cell transplantation setting using thymoglobulin® Rabbit anti-thymocyte globulins, initial results of a randomised study. EBMT 2008 41(1):s208. (Poster).
260. M.Y. Shapira*, I.B. Resnick, P.D. Tsirigotis, M. Aker, P.Stefansky, B. Gesundeheidt , R. Or. A new induction protocol with alefacept for the control of steroid efractory/dependent acute graft-versus-host disease. EBMT 2008 41(1):s208. Poster.
261. M.Y. Shapira, L. Drey*, I.B. Resnick, P.D. Tsirigotis, B. Gesundeheidt, R. Or. Post non-myeloablative allogeneic transplant therapeutic and prophylactic rituximab immunotherapy. EBMT 2008 41(1):s325. Poster
262. A. Avigdor* , Y. Vagima , P. Goichberg , O. Kollet ,S. Shivtiel , M. Tesio , A. Kalinkovich, I. Petit , O. Perl , E. Rosenthal , I. Resnick , I. Hardan , A.Nagler , T. Lapidot. MT1-MMP and RECK inversely regulate haematopoieticprogenitor cell egress. EBMT 2008 41(1):s1. Oral presentation (Award of EBMT’2008 for Basic Research).
263. M. Kedmi, I.B. Resnick, B. Gesundeheidt, L. Drey, S. Samuel, R. Or, M.Y. Shapira*. What to do when the first allogeneic stem cell transplantation fails? EBMT 2008 41(1):s9. Oral presentation.
264. M.Y. Shapira, L. Dray, I.B. Resnick, P.D. Trisigotis, B.Gesundeheidt, R. Or. Prophylactic and therapeutic post autologous transplant rituximab therapy. EBMT 2008 41(1):s166. (Poster).
265. Resnick IB, Maschan AA, Shapira MY, Balashov DN, Trakhman PE, Skorobogatova EV, Aker M, Bitan M, Slavin S, Or R. Bone Marrow Transplantation For Fanconi Anemia Using Fludarabine Based Conditioning: Joint Jerusalem-Moscow Experience (2008). EBMT 2008 41(1):s20. Oral presentation.
266. I.B. Resnick, M.Y. Shapira, C. Barkatz, L.Dray, R. Or. Early results of x-linked adrenoleukodystrophy (X-ALD) case treated with mesenchymal stem cells from matched unrelated donor.Bone Marrow Transplantation (2008) volume 42, s119. (Abstract as poster presentation p20).
267. Polina Stepensky, Claudine Barkatz, Reuven Or, Michael Shapira, Memet Aker, Michael Weintraub, Igor Resnick. Immunossupressive effect of MSC can be used for severe acute forms of GVHD in pediatrics: a single center experience. Bone Marrow Transplantation (2008) volume 42, s122. (Abstract as poster presentation p26)
268. I.B. Resnick, C. Barkatz, T.Prigozhina, G.Elkin, O. Gurevitch, M.Y. Shapira, D. Mankuta, P. Stepensky, M. Aker, R.Or. Mesenchimal stem cells (MSC) – A single center experience: from bench to bedside. ILSI-BioMed Israel 2008; 23 (oral presentation)
269. Asplund AC, De Saint Basile G, Vahliaho J, Resnick I, Vihinen M, smith CIE. 121 new families with Mutation in Bruton`s Tyrosine Kinase (BTK).Clinical and Experimental Immunology 2008, volume 154(1):91 (poster).
270. Resnick IB, Stepensky P, Weintraub M, Revel Vilk S, De la Fuente M, Notarangelo LD. Class switch recombination defect associated with EBV inbection and lymphoma: a novel form of primary immunodeficiency. Clinical and Experimental Immunology 2008, volume 154(1):217 (abstract and poster).
271. Resnick IB, Stepensky P, Weintraub M, Averbukh D, Feinberg J, Boisson-Dupuis S, Bustamante J, Casanova JL. A novel form of mendelian susceptibility to mycobacterial disease combined with myelodysplastic syndrome. Clinical and Experimental Immunology 2008, volume 154(1):221 (abstract and poster).
272. Polina Stepensky, Reuven Or, Michael Shapira, Memet Aker, Shoshana Revel-Vilk, Michael Weintraub, Jerry Stein, Isaak Yaniv, Igor Resnick. Thalassemia: bone marrow transplantation failures Bone Marrow Transplantation (2008) 42, s109. (Abstract as oral presentation o28).
273. Resnick IB, Stepensky P, Weintraub M, Revel Vilk S, De la Fuente M, Notarangelo LD. Class switch recombination defect associated with EBV inbection and lymphoma: a novel form of primary immunodeficiency. Clinical and Experimental Immunology 2008, volume 154(1):217 (case report + poster).
274. Resnick IB, Stepensky P, Weintraub M, Averbukh D, Feinberg J, Boisson-Dupuis S, Bustamante J, Casanova JL.A novel form of mendelian susceptibility to mycobacterial disease combined with myelodysplastic syndrome. . Clinical and Experimental Immunology 2008, volume 154(1):221 (case report + poster).
275. Asplund AC, De Saint Basile G, Vahliaho J, Resnick I, Vihinen M, smith CIEX-linked agammaglobulinemia (XLA) is caused by mutation affecting Brutons tyrosine kinase (BTK).Clinical and Experimental Immunology 2008, volume 154(1):91 (poster).
276. Igor Resnick, Polina Stepensky, Michael Weintraub, Dani Engelhard, Diana Averbukh, Jacqueline Feinberg, Stéphanie Boisson-Dupuis, Jacinta Bustamante, Jean-Laurent Casanova. A novel form of myelodysplastic syndrome (mds) associated with mendelian susceptibility to mycobacterial disease (MSMD). EWOG 2009, Netherlands, Rotterdam (accepted).
277. P. Stepensky, I. Yatsiv, J. Baron, M. Aker, M. Weintraub, S. Revel-Vilk, M. Shapira, R. Or, I. Resnick. Feasibility of intensive care for pediatric patients in HSCT setting. EBMT 2009, Sweden, Göteborg (poster presentation).
278. MY Shapira, R Or, M Aker, L Drey, B Gesundeheidt, S Samuel, and IB Resnick. Transplant conditioning toxicity - A comparison of 3 myeloablative protocols. EBMT 2009, Sweden, Göteborg (poster presentation).
279. MY Shapira, L Drey, IB Resnick, M Aker, P Stepansky, B Gesundeheidt, and R Or. The effect of alefacept given for steroid refractory/dependent graft vs. host disease on relapse rate.EBMT 2009, Sweden, Göteborg (poster presentation).
280. MY Shapira, L Drey, IB Resnick, et al. Non-myeloablative stem cell transplantation (NST) conditioning protocol without antithymocytic globulin. EBMT 2009, Sweden, Göteborg (poster presentation).
281. Polina Stepensky, Claudine Barkatz, Michael Weintraub, Gregory Elkin, Michael Shapira, Memet Aker, Shoshana Revel-Vilk , Reuven Or, Igor Resnick. Immunossupressive properties of mesenchymal stem/stromal cells (MSC) for treatment severe forms of acute GVHD in pediatrics. ISPHO Annual meeting 2009 (oral presentation).
282. Igor B Resnick, Tatyana Prigozhina, Gregory Elkin, Batia Avni, Michael Y Shapira, Reuven Or, Polina Stepensky, Olga Gurevich. Comparison of hematopoietic stem cell (hsc) engraftment on syngeneic and allogeneic stromal territories in the absence of immune reaction. EHA 2009, Germany, Berlin (poster presentation).
283. Igor Resnick, Polina Stepensky, Michael Shapira, Caudine Barkatz, Gregory Elkin, Olga Gurevich, Michael Weintraub, Arnon Nagler, Reuven Or Treatment of Severe Acute Graft-Versus-Host Disease with Mesenchymal Stromal Cells. ASH 2009 USA, New Orleans (oral presentation).
Future Research Program
1. Haplotype analysis with evaluation of the age of the “Russian” 657del5 NBS1 mutation, might show if there was migration of Slavs from Central Europe to the East after the 17th century after the battle of Weissenberg in the Thirty Years War, or if this mutation came from the East and contaminated the European population. This study will be done with Prof. K. Sperling (Institute of Human Genetics of Charite Humboldt University, Berlin, Germany).
2. Analysis of several genes which could be responsible for defective apoptosis in patients with ALPS and without FasL gene mutation. This investigation is planned in collaboration with the laboratory of Prof. A. Fischer (INSERM 429, Paris, France).
3. Molecular epidemiology of A-T (with the International Molecular Epidemiology Consortium for AT (IMECAT) Research Institute for Pediatric Hematology, in Moscow, Russia).
4. Time Domain Dielectric Spectroscopy as a Monitoring Tool for Determination of Cell Lymphocyte Response for Immune and Non-Immune activation. A project with the Department of Applied Physics, The Hebrew University of Jerusalem (Prof. Y. Feldman).
5. Mesenchimal stem cells and immune tolerance (my own project in Hadassah Medical Center; technician - Claudine Barkatz, MSc).
6. Self immune tolerance break: can it be helpful?
7. MSC rescue of brain damage (with Prof. Esther Shohami, School of Pharmacology, HUJI an Dr. Ido Yatziv, Hadassah).
8. Immune response of chimeras.
9. Mesenchymal progenitor cells in red and yellow bone marrow (with Neurological Science Research Center, Department of Physiology, University of Montreal, Quebec, Canada, Prof. A. Feldman)
More in PubMed